Preliminary Results of a Phase 1 Study in Healthy Subjects Administered Inclacumab, a Fully Human IgG4 Anti-P-Selectin Monoclonal Antibody in Development for Treatment of Sickle Cell Disease
Mayer, Christina, Cooper, Daniel Scott, Redfern, Andrew, Geng, Xin, Shi, Jianxia, van Zutphen-van Geffen, Mariëlle, Kuan, Isabelle, Koeck, Kathleen, Kastrissios, Helen, Patel, Kashyap, Davis, Mark, Yue, Patrick
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article